Abstract
Previous observational studies have demonstrated the development of pulmonary impairments in human T-lymphotropic virus type 1 (HTLV-1) infected individuals. The main observed lesions due to chronic inflammation of viral infection in situ are bronchiectasis and lung-scarring injuries. This lung inflammation may be the causal agent of restrictive and obstructive lung diseases, primarily in tropical spastic paraparesis/HTLV-1-associated myelopathy (TSP-HAM) patients. We conducted a prospective cohort study to compare spirometry and high-resolution computed tomography (HRCT) findings among 28 HTLV-1-carrier patients over the course of 6 years (2014-2019) (male/female: 7/21; mean age: 54.7 ± 9.5, range: 41-68 years). Chest HRCT exams revealed the development and evolution of lung lesions related to TSP-HAM: including centrilobular nodules, parenchymal bands, lung cysts, bronchiectasis, ground-glass opacity, mosaic attenuation, and pleural thickening. Spirometry exams showed maintenance of respiratory function, with few alterations in parameters suggestive of obstructive and restrictive disorders primarily in individuals with lung lesions and TSP-HAM. The findings of the present study indicate that pulmonary disease related to HTLV-1 is a progressive disease, with development of new lung lesions, mainly in individuals with TSP-HAM. To improve clinical management of these individuals, we recommend that individuals diagnosed with PET-MAH undergo pulmonary evaluation.
Highlights
Human T-lymphotropic virus type 1 (HTLV-1) is a retrovirus and has a global infection incidence of ~ 20 million people, with a higher prevalence in Africa, Japan, and Latin America [1]
To the best of our knowledge, our study is the first to compare the findings of chest computed tomography (CT) and spirometry in a cohort of patients infected with HTLV-1 over a 6-year follow-up period; we demonstrate the clinical evolution of these patients and their lung injuries related to HTLV-1
This study aimed to compare the findings of chest computed tomography (CT) and spirometry in a cohort of patients infected with HTLV-1 in a 6-year follow-up period
Summary
Human T-lymphotropic virus type 1 (HTLV-1) is a retrovirus and has a global infection incidence of ~ 20 million people, with a higher prevalence in Africa, Japan, and Latin America [1]. Brazil has a high prevalence, mainly in Maranhão, Bahia and Para States, and is most common in the Brazilian Amazon rainforest regions [2, 3]. CT Scan demonstrate the evolution of HTLV-1 Lung Injuries
Sign-in/Register to view highlights & summary Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
